TFAP2E
Transcription factor AP-2-epsilon
Also known as: AP-2epsilon, AP2E, AP2E_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6VUC0
- Gene
- TFAP2E
- Ensembl
- ENSG00000116819
- Chromosome
- 1
- Canonical length
- 442 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in positive regulation of transcription by RNA polymerase II and regulation of cell population proliferation. Predicted to be located in chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
442 residues, UniProt reviewed canonical sequence.
>Q6VUC0|TFAP2E
1 MLVHTYSAME RPDGLGAAAG GARLSSLPQA AYGPAPPLCH TPAATAAAEF QPPYFPPPYP
61 QPPLPYGQAP DAAAAFPHLA GDPYGGLAPL AQPQPPQAAW AAPRAAARAH EEPPGLLAPP
121 ARALGLDPRR DYATAVPRLL HGLADGAHGL ADAPLGLPGL AAAPGLEDLQ AMDEPGMSLL
181 DQSVIKKVPI PSKASSLSAL SLAKDSLVGG ITNPGEVFCS VPGRLSLLSS TSKYKVTVGE
241 VQRRLSPPEC LNASLLGGVL RRAKSKNGGR CLRERLEKIG LNLPAGRRKA ANVTLLTSLV
301 EGEAVHLARD FGYVCETEFP AKAAAEYLCR QHADPGELHS RKSMLLAAKQ ICKEFADLMA
361 QDRSPLGNSR PALILEPGVQ SCLTHFSLIT HGFGGPAICA ALTAFQNYLL ESLKGLDKMF
421 LSSVGSGHGE TKASEKDAKH RKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TFAP2E can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.55
- Highest tissue expression
- 9.7 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 9.7 nTPM
- retina: 3.2 nTPM
- bone marrow: 1.4 nTPM
- skin: 1.4 nTPM
- basal ganglia: 1.2 nTPM
- cerebral cortex: 1.2 nTPM
Single-cell type
- retinal bipolar cells: 73 nCPM
- retinal amacrine cells: 70 nCPM
- rod photoreceptor cells: 33 nCPM
- retinal ganglion cells: 27 nCPM
- retinal horizontal cells: 20 nCPM
- brain inhibitory neurons: 18 nCPM
Immune cell
- gdT-cell: 0.9 nTPM
- NK-cell: 0.9 nTPM
- classical monocyte: 0.8 nTPM
- memory CD8 T-cell: 0.8 nTPM
- naive CD8 T-cell: 0.8 nTPM
- T-reg: 0.8 nTPM
Brain region
- cerebellum: 19 nTPM
- white matter: 11 nTPM
- cerebral cortex: 8.2 nTPM
- pons: 7.4 nTPM
- basal ganglia: 7.1 nTPM
- medulla oblongata: 7.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.16
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.02
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of transcription by RNA polymerase II
- regulation of cell population proliferation
Molecular functions
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- identical protein binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TFAP2E as an antibody target. Whether an autoantibody or antibody against TFAP2E could matter depends on whether native TFAP2E is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TFAP2E is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TFAP2E as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...